[Causality can be shown with mendelian randomization. Cardiovascular risk relations tested with the method]

Review

. 2013 Apr;110(16):832-5.

[Article in Swedish]

Affiliations

Review

[Article in Swedish]

Peter M Nilsson. Lakartidningen. 2013 Apr.

. 2013 Apr;110(16):832-5.

No abstract available

Similar articles

Using Mendelian randomization to determine causative factors in cardiovascular disease.
Johansen CT, Hegele RA. Johansen CT, et al. J Intern Med. 2013 Jan;273(1):44-7. doi: 10.1111/j.1365-2796.2012.02586.x. Epub 2012 Sep 24. J Intern Med. 2013. PMID: 22928522 No abstract available.
Mendelian randomization: how genetics is pushing the boundaries of epidemiology to identify new causes of heart disease.
Thanassoulis G. Thanassoulis G. Can J Cardiol. 2013 Jan;29(1):30-6. doi: 10.1016/j.cjca.2012.09.014. Epub 2012 Nov 29. Can J Cardiol. 2013. PMID: 23199790 Review.
From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment.
Benn M, Nordestgaard BG. Benn M, et al. Cardiovasc Res. 2018 Jul 15;114(9):1192-1208. doi: 10.1093/cvr/cvy045. Cardiovasc Res. 2018. PMID: 29471399 Review.
Genetic markers of inflammation and their role in cardiovascular disease.
Raman K, Chong M, Akhtar-Danesh GG, D'Mello M, Hasso R, Ross S, Xu F, Paré G. Raman K, et al. Can J Cardiol. 2013 Jan;29(1):67-74. doi: 10.1016/j.cjca.2012.06.025. Epub 2012 Sep 19. Can J Cardiol. 2013. PMID: 22999193 Review.
Power and sample size calculations for Mendelian randomization studies using one genetic instrument.
Freeman G, Cowling BJ, Schooling CM. Freeman G, et al. Int J Epidemiol. 2013 Aug;42(4):1157-63. doi: 10.1093/ije/dyt110. Epub 2013 Aug 9. Int J Epidemiol. 2013. PMID: 23934314